NCT01890785View on ClinicalTrials.gov

Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 15, 2013

Primary Completion Date

August 22, 2013

Study Completion Date

August 22, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Lisdexamfetamine Dimesylate

Single dose of a 70 mg capsule on Day 1

Trial Locations (1)

Unknown

Clinical Pharmacology of Miami, Inc, Miami

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT01890785 - Bioavailability Study of SPD489 Administered With Two Different Means of Administration in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter